Antônio da Silva

691 total citations
20 papers, 559 citations indexed

About

Antônio da Silva is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Antônio da Silva has authored 20 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Oncology. Recurrent topics in Antônio da Silva's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Biosimilars and Bioanalytical Methods (8 papers) and CAR-T cell therapy research (6 papers). Antônio da Silva is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Biosimilars and Bioanalytical Methods (8 papers) and CAR-T cell therapy research (6 papers). Antônio da Silva collaborates with scholars based in United States, Switzerland and United Kingdom. Antônio da Silva's co-authors include Christopher E. Rudd, Monika Raab, Hyun Kang, Xiaochun Zhu, Ulrich Kronthaler, Kartik Prasad, Grit Lorenczewski, Bernd Schlereth, Klaus Brischwein and Patrick A. Baeuerle and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Antônio da Silva

20 papers receiving 514 citations

Peers

Countries citing papers authored by Antônio da Silva

Since Specialization

Citations

This map shows the geographic impact of Antônio da Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antônio da Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antônio da Silva more than expected).

Fields of papers citing papers by Antônio da Silva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antônio da Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antônio da Silva. The network helps show where Antônio da Silva may publish in the future.

Co-authorship network of co-authors of Antônio da Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Antônio da Silva. A scholar is included among the top collaborators of Antônio da Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antônio da Silva. Antônio da Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts 2021 ·Cochrane Database of Systematic Reviews ·I. Mohamed, (unknown), Antônio da Silva	9
2	Reinfection in a large cohort of prison inmates with sustained virological response after treatment of chronic hepatitis C in Catalonia (Spain), 2002–2016 2019 ·International Journal of Drug Policy ·Andrés Marco, Rafael Guerrero, Mercedes Vergara, (unknown), (unknown), (unknown), (unknown), Núria Teixidó, (unknown), (unknown), Antônio da Silva, (unknown), (unknown), Joan A. Caylà, (unknown)	13
3	Scientific Rationale Underpinning the Development of Biosimilar Rituximab in Hematological Cancers and Inflammatory Diseases 2019 ·Future Oncology ·Wojciech Jurczak, Stanley Cohen, Tim Illidge, Antônio da Silva, (unknown)	8
4	Comparative functional and pharmacological characterization of Sandoz proposed biosimilar adalimumab (GP2017): rationale for extrapolation across indications 2018 ·Expert Opinion on Biological Therapy ·Ulrich Kronthaler, Cornelius Fritsch, Otmar Hainzl, Andreas Seidl, Antônio da Silva	23
5	Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges 2016 ·mAbs ·Kathryn Chapman, (unknown), Paul Baldrick, Antônio da Silva, Karen De Smet, (unknown), (unknown), David Jones, Michael W. Leach, James W. McBlane, Ian Ragan, Praveen Reddy, (unknown), Amanda Suitters, Jennifer Sims	28
6	Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel^®) 2016 ·Expert Opinion on Biological Therapy ·(unknown), Ulrich Kronthaler, Cornelius Fritsch, R. Grau, (unknown), (unknown), Andreas Seidl, Antônio da Silva	25
7	Non-clinical Pharmacological Characterization and In-Vivo Efficacy of the Proposed Adalimumab Biosimilar GP2017 Compared to the Originator Adalimumab 2016 ·The American Journal of Gastroenterology ·Antônio da Silva, Cornelius Fritsch, Ulrich Kronthaler, (unknown), Otmar Hainzl, Andreas Seidl	1
8	Target-directed development and preclinical characterization of the proposed biosimilar rituximab GP2013 2013 ·Leukemia & lymphoma ·Antônio da Silva, Ulrich Kronthaler, (unknown), Martin Fink, (unknown), (unknown), Matthias Hofmann, Thomas Stangler, (unknown)	33
9	The Influence of Whole-Body Vibration on Creatine Kinase Activity and Jumping Performance in Young Basketball Players 2013 ·Research Quarterly for Exercise and Sport ·(unknown), Antônio da Silva, William R. Falcão, (unknown), João Paulo Borin, Fábio C. Minozzo, (unknown), Rodrigo Luiz Vancini, Brach Poston, Claudio André Barbosa de Lira	4
10	Physicochemical, functional, and pharmacologic comparability between the proposed biosimilar rituximab GP2013 and originator rituximab as the foundation for biosimilarity. 2013 ·Journal of Clinical Oncology ·Antônio da Silva, Ulrich Kronthaler, (unknown), Cornelius Fritsch, (unknown), Thomas Stangler, (unknown)	3
11	Target-Directed Development of a Proposed Biosimilar Rituximab (GP2013): Comparability of Antibody-Dependent Cellular Cytotoxicity Activity and Pre-Clinical Pharmacokinetics and Pharmacodynamics with Originator Rituximab 2012 ·Blood ·Antônio da Silva, Ulrich Kronthaler, (unknown), (unknown), Thomas Stangler, (unknown)	4
12	Spontaneous splenic rupture in the postpartum period 2008 ·British Journal of Hospital Medicine ·Sharath C.V. Paravastu, (unknown), Antônio da Silva	1
13	Exchanging human Fcγ1 with murine Fcγ2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model 2006 ·Cancer Immunology Immunotherapy ·Petra Lutterbuese, Klaus Brischwein, Robert Hofmeister, (unknown), Grit Lorenczewski, (unknown), (unknown), Antônio da Silva, Mathias Locher, Patrick A. Baeuerle, Bernd Schlereth	10
14	A importância da atuação odontológica em pacientes internados em unidade de terapia intensiva 2006 ·Revista Brasileira de Terapia Intensiva ·(unknown), Antônio da Silva, (unknown), (unknown), Elias Knobel, Luís Fernando Aranha Camargo	33
15	Eradication of Tumors from a Human Colon Cancer Cell Line and from Ovarian Cancer Metastases in Immunodeficient Mice by a Single-Chain Ep-CAM-/CD3-Bispecific Antibody Construct 2005 ·Cancer Research ·Bernd Schlereth, Iduna Fichtner, Grit Lorenczewski, Petra Kleindienst, Klaus Brischwein, Antônio da Silva, Peter Kufer, Ralf Lutterbuese, I Junghahn, Sabine Kasimir‐Bauer, Pauline Wimberger, Rainer Kimmig, Patrick A. Baeuerle	101
16	Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3 2005 ·Cancer Immunology Immunotherapy ·Bernd Schlereth, Petra Kleindienst, Iduna Fichtner, Grit Lorenczewski, Klaus Brischwein, (unknown), Antônio da Silva, Mathias Locher, Roman Kischel, Ralf Lutterbüse, Peter Kufer, Patrick A. Baeuerle	44
17	FYN-T-FYB-SLP-76 Interactions Define a T-cell Receptor ζ/CD3-mediated Tyrosine Phosphorylation Pathway That Up-regulates Interleukin 2 Transcription in T-cells 1999 ·Journal of Biological Chemistry ·Monika Raab, Hyun Kang, Antônio da Silva, Xiaochun Zhu, Christopher E. Rudd	94
18	Human CD4/CD45RA⁺ and CD4/CD45RA⁻ T cell subsets express CD4-p56^lck complexes, CD4-associated lipid kinases, TCR/CD3-p59^fyn complexes, and share similar tyrosine kinase substrates 1993 ·International Immunology ·David M. Rothstein, Antônio da Silva, Kanji Sugita, Masahiro Yamamoto, Kartik Prasad, Chikao Morimoto, (unknown), Christopher E. Rudd	15
19	src-related protein tyrosine kinases and their surface receptors 1993 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Christopher E. Rudd, Ottmar Janßen, Kartik Prasad, Monika Raab, Antônio da Silva, Janice C. Telfer, Masahiro Yamamoto	76
20	Pharmacological Trials of Crude Extract ofPassiflora alata 1984 ·Planta Medica ·Seizi Oga, (unknown), Antônio da Silva, (unknown)	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact